Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests

Clinical Endocrinology

Volumn 69, Issue 1, 2008, Pages 148-152

  Antonelli, Alessandro ^a   Ferrari, Silvia Martina ^a   Fallahi, Poupak ^a   Berti, Piero ^a   Materazzi, Gabriele ^a   Barani, Lucio ^a   Marchetti, Ivo ^b   Ferrannini, Ele ^a   Miccoli, Paolo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; TETRAZOLIUM;

ARTICLE; ASPIRATION BIOPSY; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RADIOSENSITIVITY; THYROID CANCER;

ANTINEOPLASTIC AGENTS; BIOPSY, FINE-NEEDLE; BLEOMYCIN; CARCINOMA; CELL COUNT; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CISPLATIN; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ETOPOSIDE; HUMANS; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 45349089614     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03182.x     Document Type: Article

References (31)

1. Shaha, A.R. (2004) Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope, 114, 393 402.
2. Nel, C.J., van Heerden, J.A., Goellner, J.R., Gharib, H., McConahey, W.M., Taylor, W.F. Grant, C.S. (1985) Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clinic Proceedings, 60, 51 58.
3. Tan, R.K., Finley, R.K. 3rd., Driscoll, D., Bakamjian, V., Hicks, W.L. Jr. & Shedd, D.P. (1995) Anaplastic carcinoma of the thyroid: a 24-year experience. Head and Neck, 17, 41 48.
4. Carty, S. (2001) Anaplastic thyroid cancer. In : G.M. Doherty, B. Skogseid eds. Surgical Endocrinology. Lippincott Williams & Wilkins, Philadelphia, 127 134.
5. Giuffrida, D. Gharib, H. (2000) Anaplastic thyroid carcinoma: current diagnosis and treatment. Annals of Oncology, 11, 1083 1089.
6. Busnardo, B., Daniele, O., Pelizzo, M.R., Mazzarotto, R., Nacamulli, D., Devido, D., Mian, C. Girelli, M.E. (2000) A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients. Journal of Endocrinological Investigation, 23, 755 761.
7. Haddad, R., Mahadevan, A., Posner, M.R. Sullivan, C. (2005) Long term survival with adjuvant carboplatin, paclitaxel, and radiation therapy in anaplastic thyroid cancer. American Journal of Clinical Oncology, 28, 104.
8. Haigh, P.I., Ituarte, P.H., Wu, H.S., Treseler, P.A., Posner, M.D., Quivey, J.M., Duh, Q.Y. Clark, O.H. (2001) Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer, 91, 2335 2342.
9. Kobayashi, T., Asakawa, H., Umeshita, K., Takeda, T., Maruyama, H., Matsuzuka, F. Monden, M. (1996) Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head and Neck, 18, 36 41.
10. Junor, E.J., Paul, J. Reed, N.S. (1992) Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. European Journal of Surgical Oncology, 18, 83 88.
11. Miccoli, P., Materazzi, G., Antonelli, A., Panicucci, E., Frustaci, G. Berti, P. (2006) New trends in the treatment of undifferentiated carcinomas of the thyroid. Langenbeck's Archives of Surgery.
12. Newell, D.R. (2001) Flasks, fibres and flanks - pre-clinical tumour models for predicting clinical antitumour activity. British Journal of Cancer, 84, 1289 1290.
13. Dollner, R., Granzow, C., Werner, J.A. Dietz, A. (2004) Is there a role for chemosensitivity tests in head and neck cancer? Onkologie, 27, 310 315.
14. Schroyens, W., Tueni, E., Dodion, P., Bodecker, R., Stoessel, F. Klastersky, J. (1990) Validation of clinical predictive value of in vitro colorimetric chemosensitivity assay in head and neck cancer. European Journal of Cancer, 26, 834 838.
15. Voigt, W., Bulankin, A., Muller, T., Schoeber, C., Grothey, A., Hoang-Vu, C. Schmoll, H.J. (2000) Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid cancer cell lines. Clinical Cancer Research, 6, 2087 2093.
16. Ain, K.B., Egorin, M.J. DeSimone, P.A. (2000) Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid, 10, 587 594.
17. Copland, J.A., Marlow, L.A., Kurakata, S., Fujiwara, K., Wong, A.K., Kreinest, P.A., Williams, S.F., Haugen, B.R., Klopper, J.P. Smallridge, R.C. (2006) Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1. Oncogene, 25, 2304 2317.
18. Fiore, L., Pollina, L.E., Fontanini, G., Casalone, R., Berlingieri, M.T., Giannini, R., Pacini, F., Miccoli, P., Toniolo, A., Fusco, A. Basolo, F. (1997) Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1. Journal of Clinical Endocrinology and Metabolism, 82, 4094 4100.
19. Berridge, M.V., Herst, P.M. Tan, A.S. (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnology Annual Review, 11, 127 152.
20. Gillman, G. (2005) The Pharmacological Basis of Therapeutics. McGraw-Hill, New York.
21. Fridborg, H., Nygren, P. Larsson, R. (1995) Relationship between pharmacokinetic parameters in patients and cytotoxicity in vitro of standard and investigational anticancer drugs. Anticancer Drugs, 6, 64 69.
22. Abbruzzese, J.L., Grunewald, R., Weeks, E.A., Gravel, D., Adams, T., Nowak, B., Mineishi, S., Tarassoff, P., Satterlee, W. Raber, M.N. (1991) A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. Journal of Clinical Oncology, 9, 491 498.
23. Millward, M.J., Newell, D.R., Mummaneni, V., Igwemezie, L.N., Balmanno, K., Charlton, C.J., Gumbrell, L., Lind, M.J., Chapman, F., Proctor, M., Simmonds, D., Cantwell, B.M.J., Taylor, G.A., McDaniel, C., Winograd, B., Kaul, S., Barbaiya, R.H. Calvert, A.H. (1995) Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481). European Journal of Cancer, 31A, 2409 2411.
24. McIver, B., Hay, I.D., Giuffrida, D.F., Dvorak, C.E., Grant, C.S., Thompson, G.B., van Heerden, J.A. Goellner, J.R. (2001) Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery, 130, 1028 1034.
25. Kebebew, E., Greenspan, F.S., Clark, O.H., Woeber, K.A. McMillan, A. (2005) Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer, 103, 1330 1335.
26. De Crevoisier, R., Baudin, E., Bachelot, A., Leboulleux, S., Travagli, J.P., Caillou, B. Schlumberger, M. (2004) Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 60, 1137 1143.
27. Kihara, M., Miyauchi, A., Yamauchi, A. Yokomise, H. (2004) Prognostic factors of anaplastic thyroid carcinoma. Surgery Today, 34, 394 398.
28. Force, T.C.T. (2001) AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocrine Practice, 7, 202 220.
29. Holting, T., Meybier, H. Buhr, H. (1990) Status of tracheotomy in treatment of the respiratory emergency in anaplastic thyroid cancer [in German]. Wiener Klinische Wochenschrift, 102, 264 266.
30. Huang, J.W., Shiau, C.W., Yang, Y.T., Kulp, S.K., Chen, K.F., Brueggemeier, R.W., Shapiro, C.L. Chen, C.S. (2005) Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Molecular Pharmacology, 67, 1342 1348.
31. Abelardo, E., Jaramillo, M., Sheffield, E. Tierney, P. (2007) Anaplastic thyroid carcinoma implantation after fine needle aspiration cytology. Journal of Laryngology and Otology, 121, 268 270.